Electrolyte solutions and in vivo use thereof

Claim 2

An aqueous solution suitable for fluid therapy comprising on the basis of 1 liter of solution about 130 to 165 mM sodium, about 80 to 130 mM chloride, and about 0.5 to 60 mM at least one of the following: (a) l-lactate and pyruvate, the l-lactate to pyruvate ratio being about 20:1 to 1:1, (b) d-beta hydroxybutyrate and acetoacetate, the d-beta hydroxybutyrate to acetoacetate ratio being about 6:1 to 0.5:1, the sodium to chloride ratio being about 1.24 to 1.6, and the pH ranging from about 5 to 9.

Claim 3

A solution in accordance with claim 1 containing from about 0.5 to 5 mM calcium.

Claim 4

A solution in accordance with claim 1 containing from about 0.5 to 3 mM magnesium.

Claim 5

A solution in accordance with claim 1 containing from about 0.5 to 10 mM potassium.

Claim 6

A solution in accordance with claim 1 containing from 0 to about 300 mM glucose.

Claim 7

A solution in accordance with claim 1 containing from about 0.5 to 60 mM of bicarbonate and carbon dioxide, the bicarbonate to carbon dioxide ratio being about 0.1:1 to 55:0.1.

Claim 8

An electrolyte solution suitable for dilution and for resuscitation therapy comprising on the basis of 1 liter of solution 160 to 2400 mM sodium and sufficient mM chloride to produce a sodium to chloride ratio from about 1.24 to 1.6, and from about 80 to 465 mM of at least one of the following: (a) l-lactate and pyruvate, the l-lactate to pyruvate ratio being about 20:1 to 1:1, (b) d-beta hydroxybutyrate and acetoacetate, the d-beta-hydroxybutyrate to acetoacetate ratio being about 6:1 to 0.5:1, the pH being about 5 to 9.

Claim 9

An electrolyte solution suitable for dilution and for resuscitation therapy comprising on the basis of 1 liter of solution 160 to 2400 mM sodium and sufficient mM chloride to produce a sodium to chloride ratio from about 1.24 to 1.6, and from about 80 to 465 mM of at least one of the following: (a) l-lactate and pyruvate, the l-lactate to pyruvate ratio being about 20:1 to 1:1, (b) d-beta hydroxybutyrate and acetoacetate, the d-beta-hydroxybutyrate to acetoacetate ratio being about 6:1 to 0.5:1, the pH being about 5 to 9.

Claim 10

The solution of claim 7 which has been diluted with an aqueous dextrose solution to produce a product solution containing less than about 130 mM sodium.

Claim 11

An in vivo process for maintaining normal cellular free [NAD + ]/[NADH] ratios and phosphorylation states which comprises introducing parenterally into a living mammal a physiologically effective amount an aqueous solution comprising on the basis of 1 liter of solution about 130 to 165 mM sodium, about 80 to 130 mM chloride, and about 0.5 to 80 mM of at least one of the following: (a) l-lactate and pyruvate, the l-lactate to pyruvate ratio being about 20:1 to 1:1, (b) d-beta hydroxybutyrate and acetoacetate, the d-betahydroxybutyrate to acetoacetate ratio being about 6:1 to 0.5:1, the sodium to chloride ratio being about 1.24 to 1.6, and the pH ranging from about 5 to 9.

Claim 12

An in vivo process for maintaining normal cellular free [NAD + ]/[NADH] ratios and phosphorylation states which comprises introducing parenterally into a living mammal a physiologically effective amount an aqueous solution comprising on the basis of 1 liter of solution about 130 to 165 mM sodium, about 80 to 130 mM chloride, and about 0.5 to 80 mM of at least one of the following: (a) l-lactate and pyruvate, the l-lactate to pyruvate ratio being about 20:1 to 1:1, (b) d-beta hydroxybutyrate and acetoacetate, the d-betahydroxybutyrate to acetoacetate ratio being about 6:1 to 0.5:1, the sodium to chloride ratio being about 1.24 to 1.6, and the pH ranging from about 5 to 9.

Claim 13

The process of claim 9 wherein said solution additionally contains from 0 to about 300 mM glucose.

Claim 14

The process of claim 9 wherein said solution additionally contains about 10 to 60 mM bicarbonate and carbon dioxide, the bicarbonate to carbon dioxide ratio being about 0.1:1 to 55:0.1 and wherein the free cytosolic [NADP + ]/[NADPH] ratios are also maintained.

Claim 15

In a process where renal function of a living mammal is replaced by dialysis and wherein the dialysis fluid contains dissolved therein from about 130 to 165 mM sodium, and also from about 81 to 130 mM chloride, and said fluid has a sodium to chloride ratio ranging from about 1.24 to 1.6, a pH from about 5 to 9, and a milliosmolarity from about 260 to 800, the improvement which comprises including in said dialysis fluid from about 25 to 455 mM of at least one of the following substance pairs in the respective concentrations indicated: from about 0 to 55 mM bicarbonate and carbon dioxide, the bicarbonate to carbon dioxide ratio being 0.1:1 to 55:0.1, from about 0 to 55 mM of l-lactate and pyruvate, the l-lactate to pyruvate ratio being 20:1 to 1:1, and from about 0 to 55 mM of d-betahydroxybutyrate and acetoacetate, the d-betahydroxybutyrate to acetoacetate ratio being 6:1 to 0.5:1.

Claim 16

In a process where renal function of a living mammal is replaced by dialysis and wherein the dialysis fluid contains dissolved therein from about 130 to 165 mM sodium, and also from about 81 to 130 mM chloride, and said fluid has a sodium to chloride ratio ranging from about 1.24 to 1.6, a pH from about 5 to 9, and a milliosmolarity from about 260 to 800, the improvement which comprises including in said dialysis fluid from about 25 to 455 mM of at least one of the following substance pairs in the respective concentrations indicated: from about 0 to 55 mM bicarbonate and carbon dioxide, the bicarbonate to carbon dioxide ratio being 0.1:1 to 55:0.1, from about 0 to 55 mM of l-lactate and pyruvate, the l-lactate to pyruvate ratio being 20:1 to 1:1, and from about 0 to 55 mM of d-betahydroxybutyrate and acetoacetate, the d-betahydroxybutyrate to acetoacetate ratio being 6:1 to 0.5:1.

Claim 17

The process of claim 8 wherein said solution additionally contains from 0 to about 45 mM bicarbonate.

Claim 18

The process of claim 13 wherein said pH of said solution is achieved by admixture of said bicarbonate to said carboxylic acid and wherein the final concentrations thereof are such as to produce a pH in said solution which satisfies the relationship: ##EQU8## wherein: pK a' is defined as the apparent dissociation constant of carbonic acid under physiological conditions at physiological temperature and ionic strength and is taken to be 6.1, [HCO 3 -] is the concentration of bicarbonate present in said solution, [HA] is the concentration of said carboxylic acid, and pH is conventionally defined as the negative logarithm to the base ten of the hydrogen ion concentration of the resulting said solution.

Claim 19

The process of claim 13 wherein said carbon dioxide is produced in situ by including in said solution a dissolved mixture of (A) at least one member of the group consisting of physiologically acceptable bicarbonate salts, and (B) at least one carboxylic acid selected from the group consisting of l-lactic acid, pyruvic acid, d-betahydroxybutyric acid, and acetoacetic acid, and provided that: (a) the total molar quantity of said carboxylic acid and the total molar quantity of said bicarbonate salts is such that there is produced in said solution a quantity of dissolved carbon dioxide sufficient to make said mole ratio of said bicarbonate anions to said carbon dioxide fall in within said range, and (b) the total quantity of all bicarbonate anions remains within a value such that said mole ratio of said bicarbonate anions in said solution to said carbon dioxide falls within said range, and (c) the total individual quantities of said respective carboxylic acids is such that said mole ratio of l-lactate to pyruvate, and said mole ratio of d-betahydroxybutyrate to acetoacetate each remain within said respective ranges.